Home › Companies › Utah Medical Products, Inc. › 2025-2026

Utah Medical Products, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Utah Medical Products, Inc.’s Form 8-K, filed May 4, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 5Reported items
  • 155Asset managers
  • 657Fund votes
  • May 1, 2026Meeting date

Results at a glance

Meeting of May 1, 2026: 3 items on Utah Medical Products, Inc.’s Form 8-K, filed May 4, 2026: 3 without a stated outcome.

Material dissent

  • Elected James H. Beeson as a director of the Company: 71% of votes cast Outcome not stated Under 80%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Utah Medical Products, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Utah Medical Products, Inc.

These tallies are Utah Medical Products, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 4, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Utah Medical Products, Inc. — official shareholder meeting results, meeting held May 1, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elected James H. Beeson as a director of the Company: 1,708,941---- 692,032372,329 71%Not verified—
Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2026: 2,753,27816,2733,751 ---- 99.4%Not verified—
Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: 2,354,91938,4517,603 --372,329 98%Not verified—

Source: Utah Medical Products, Inc., Form 8-K, filed with the SEC on May 4, 2026 — read the filing on EDGAR.

How asset managers voted at the Utah Medical Products, Inc. 2025-2026 meeting

Each item below shows how the 155 asset managers that disclosed a Utah Medical Products, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Utah Medical Products, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors are…: Ernst G. Hoyer

No official matchDIRECTOR ELECTIONS

Combines 5 wordings of this item as funds reported it.

47.6% of fund votes cast · no official result

FORWITHHOLD
Details: description as filed, votes by 52 asset managers

Description as filed by funds: To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors are elected and qualified: Ernst G. Hoyer

The 52 asset managers below reported 355,798 for, 390,936 withheld, 1 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 355,798ABSTAIN: 1WITHHOLD: 390,936
Largest asset managers voting on “To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors are elected and” at Utah Medical Products, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Datum One Series Trust00 0169,724Withhold
Vanguard153,8670 173For
Fidelity00 0107,545Withhold
BlackRock89,0240 00For
Dimensional00 048,242Withhold
HOTCHKIS & WILEY FUNDS /DE/21,8000 00For
ADVISORS SERIES TRUST17,5950 00For
Principal16,2870 00For
CLEARWATER INVESTMENT TRUST00 014,602Withhold
Charles Schwab00 010,532Withhold
WisdomTree00 09,439Withhold
Prudential/PGIM8,0000 0497Mixed
Equitable5,1150 03,250Mixed
American Century7,2630 00For
Columbia Threadneedle00 07,100Withhold
Empower6,5000 00For
TIAA00 05,619Withhold
QUANTITATIVE MASTER SERIES LLC5,0350 00For
BRIDGEWAY FUNDS INC5,0000 00For
EA Series Trust3,2780 00For
Northern Trust00 03,227Withhold
Invesco3,1220 00For
Series Portfolios Trust00 03,100Withhold
Goldman Sachs2,7150 00For
Lincoln Financial00 01,985Withhold

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

2. To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors are…: James H. Beeson

No official matchDIRECTOR ELECTIONS

Combines 5 wordings of this item as funds reported it.

69% of fund votes cast · no official result

FORWITHHOLD
Details: description as filed, votes by 52 asset managers

Description as filed by funds: To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors are elected and qualified: James H. Beeson

The 52 asset managers below reported 514,264 for, 232,470 withheld, 1 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 514,264ABSTAIN: 1WITHHOLD: 232,470
Largest asset managers voting on “To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors are elected and” at Utah Medical Products, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Datum One Series Trust00 0169,724Withhold
Vanguard153,9400 10For
Fidelity107,5450 00For
BlackRock89,0240 00For
Dimensional00 048,242Withhold
HOTCHKIS & WILEY FUNDS /DE/21,8000 00For
ADVISORS SERIES TRUST17,5950 00For
Principal16,2870 00For
CLEARWATER INVESTMENT TRUST14,6020 00For
Charles Schwab10,5320 00For
WisdomTree9,4390 00For
Prudential/PGIM8,0000 0497Mixed
Equitable5,1150 03,250Mixed
American Century7,2630 00For
Columbia Threadneedle7,1000 00For
Empower6,5000 00For
TIAA00 05,619Withhold
QUANTITATIVE MASTER SERIES LLC5,0350 00For
BRIDGEWAY FUNDS INC5,0000 00For
EA Series Trust3,2780 00For
Northern Trust3,2270 00For
Invesco3,1220 00For
Series Portfolios Trust3,1000 00For
Goldman Sachs2,7150 00For
Lincoln Financial00 01,985Withhold

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

3. Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation…

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 2,354,919AGAINST: 38,451
Details: description as filed, official tally, votes by 117 asset managers

Description as filed by funds: To hold an advisory vote on the Company's executive compensation program.

Utah Medical Products, Inc.’s own tally for this item (“Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:”): 2,354,919 for, 38,451 against, per its Form 8-K filed May 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 43 asset managers voting on “To hold an advisory vote on the Company's executive compensation program.” at Utah Medical Products, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard153,5710 00For
Fidelity107,5450 00For
BlackRock89,0240 00For
Dimensional48,2420 00For
HOTCHKIS & WILEY FUNDS /DE/21,8000 00For
ADVISORS SERIES TRUST17,5950 00For
Principal16,2870 00For
WisdomTree9,4390 00For
Prudential/PGIM8,4970 00For
Equitable8,3650 00For
American Century7,2630 00For
Columbia Threadneedle7,1000 00For
TIAA5,6190 00For
QUANTITATIVE MASTER SERIES LLC5,0350 00For
BRIDGEWAY FUNDS INC5,0000 00For
EA Series Trust3,2780 00For
Northern Trust3,2270 00For
Invesco3,1220 00For
Goldman Sachs2,7150 00For
RBB FUND, INC.2,4810 00For
Lincoln Financial1,9850 00For
AIG/SunAmerica1,3890 00For
Brighthouse1,2930 00For
John Hancock1,2160 00For
Jackson National1,1600 00For

Fund voting reports, all 43 managers: 540,862 for. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 88 asset managers voting on “To hold an advisory vote on the Company's executive compensation program.” at Utah Medical Products, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Renaissance139,7990 00For
GEODE CAPITAL MANAGEMENT, LLC117,5770 00For
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC83,4610 00For
BlackRock67,3000 00For
State Street51,55345 00For
T. Rowe Price33,4130 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC29,4630 00For
Cardinal Capital Management25,7400 00For
Vanguard21,9170 00For
Northern Trust19,4410 00For
Huber Capital Management LLC18,3200 00For
Dimensional18,1960 00For
SEGALL BRYANT & HAMILL, LLC16,0210 00For
Newton Investment Management North America, LLC15,7000 00For
LPL Financial LLC11,6380 00For
O'SHAUGHNESSY ASSET MANAGEMENT, LLC9,9710 00For
MELLON INVESTMENTS Corp9,3000 00For
RBC Capital Markets, LLC8,7220 00For
American Century7,2630 00For
DE Shaw7,2270 00For
MERCER GLOBAL ADVISORS INC /ADV7,1560 00For
ENVESTNET ASSET MANAGEMENT INC5,8730 00For
Nuveen5,6690 00For
AllianceBernstein5,3000 00For
BRIDGEWAY CAPITAL MANAGEMENT, LLC5,0000 00For

Institutional-manager reports, all 88 managers: 772,931 for, 2,380 against, 35 not voted. Showing the 25 largest; see all in the interactive database.

4. Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation…

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

98% Majority: yes · of votes cast

FOR 98%
FOR: 2,354,919AGAINST: 38,451
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: To approve, by advisory vote, the Company's executive compensation program.

Utah Medical Products, Inc.’s own tally for this item (“Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:”): 2,354,919 for, 38,451 against, per its Form 8-K filed May 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 11 asset managers voting on “To approve, by advisory vote, the Company's executive compensation program.” at Utah Medical Products, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Datum One Series Trust169,7240 00For
CLEARWATER INVESTMENT TRUST14,6020 00For
Charles Schwab10,5320 00For
Series Portfolios Trust3,1000 00For
Global X1,3770 00For
SEI7000 00For
NEW COVENANT FUNDS5150 00For
Nationwide4220 00For
Vanguard3700 00For
JPMorgan2560 00For
Venerable Variable Insurance Trust2560 00For

Fund voting reports, all 11 managers: 201,854 for.

Institutional-manager reports: 28 asset managers voting on “To approve, by advisory vote, the Company's executive compensation program.” at Utah Medical Products, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BRANDES INVESTMENT PARTNERS, LP215,9680 00For
RICE HALL JAMES & ASSOCIATES, LLC61,4570 00For
Charles Schwab11,2540 00For
LSV ASSET MANAGEMENT7,7001,229 00Mixed
Penobscot Investment Management Company, Inc.4,0000 00For
Metis Global Partners, LLC3,4470 00For
Acuitas Investments, LLC3,1000 00For
MACKENZIE FINANCIAL CORP2,0400 00For
NEW YORK STATE COMMON RETIREMENT FUND1,4290 00For
WASHINGTON STATE INVESTMENT BOARD1,1440 00For
SEI1,1330 00For
Universal-Investment-Gesellschaft mbH1,0000 00For
Neuberger Berman7320 00For
Summit Trail Advisors, LLC6540 00For
BANK OF AMERICA NA4660 00For
XPONANCE LLC21419 00Against
Russell Investments3000 00For
Prudential/PGIM2600 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM0251 00Against
NISA INVESTMENT ADVISORS, LLC0198 00Against
Ethic Inc.0155 00Against
Donor Advised Charitable Giving, Inc.00 00Not Voted
STATE OF MICHIGAN RETIREMENT SYSTEM1000 00For
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM550 00For
Aletheian Wealth Advisors LLC510 00For

Institutional-manager reports, all 28 managers: 316,384 for, 2,252 against, 135 not voted. Showing the 25 largest; see all in the interactive database.

5. Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 2,753,278AGAINST: 16,273
Details: description as filed, official tally, votes by 52 asset managers

Description as filed by funds: To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year ending December 31, 2026; and

Utah Medical Products, Inc.’s own tally for this item (“Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2026:”): 2,753,278 for, 16,273 against, per its Form 8-K filed May 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 52 asset managers below reported 746,735 for.

FOR
FOR: 746,735
Largest asset managers voting on “To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year e” at Utah Medical Products, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Datum One Series Trust169,7240 00For
Vanguard153,9410 00For
Fidelity107,5450 00For
BlackRock89,0240 00For
Dimensional48,2420 00For
HOTCHKIS & WILEY FUNDS /DE/21,8000 00For
ADVISORS SERIES TRUST17,5950 00For
Principal16,2870 00For
CLEARWATER INVESTMENT TRUST14,6020 00For
Charles Schwab10,5320 00For
WisdomTree9,4390 00For
Prudential/PGIM8,4970 00For
Equitable8,3650 00For
American Century7,2630 00For
Columbia Threadneedle7,1000 00For
Empower6,5000 00For
TIAA5,6190 00For
QUANTITATIVE MASTER SERIES LLC5,0350 00For
BRIDGEWAY FUNDS INC5,0000 00For
EA Series Trust3,2780 00For
Northern Trust3,2270 00For
Invesco3,1220 00For
Series Portfolios Trust3,1000 00For
Goldman Sachs2,7150 00For
Lincoln Financial1,9850 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

Largest Utah Medical Products, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 3,185,025 shares outstanding at the time of that meeting.

Fund voting reports: top Utah Medical Products, Inc. shareholders by shares voted on “To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors…”, 2025-2026
#Asset manager % of shares outstanding
1Datum One Series Trust 5.33%
2Vanguard 4.83%
3Fidelity 3.38%
4BlackRock 2.80%
5Dimensional 1.51%
6HOTCHKIS & WILEY FUNDS /DE/ 0.68%
7ADVISORS SERIES TRUST 0.55%
8Principal 0.51%
9CLEARWATER INVESTMENT TRUST 0.46%
10Charles Schwab 0.33%
Institutional-manager reports: top Utah Medical Products, Inc. shareholders by shares voted on “To hold an advisory vote on the Company's executive compensation program.”, 2025-2026
#Asset manager % of shares outstanding
1Renaissance 4.39%
2GEODE CAPITAL MANAGEMENT, LLC 3.69%
3HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.62%
4BlackRock 2.11%
5State Street 1.62%
6T. Rowe Price 1.05%
7PARAMETRIC PORTFOLIO ASSOCIATES LLC 0.93%
8Cardinal Capital Management 0.81%
9Vanguard 0.69%
10Northern Trust 0.61%

Reported Utah Medical Products, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Utah Medical Products, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
BRANDES INVESTMENT PARTNERS, LP 14.92% 13G
Dimensional Fund Advisors 6.21% 13F
BlackRock 5.89% 13F
Renaissance Technologies 5.78% 13F
Vanguard Group 5.52% 13F
Geode Capital 3.77% 13F
State Street 2.02% 13F
Morgan Stanley 1.37% 13F
BNY Mellon 1.01% 13F
Northern Trust 0.95% 13F

Percentages above are of 3,185,025 shares outstanding, as reported by Utah Medical Products, Inc. on its Form 10-K dated March 26, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Utah Medical Products, Inc.’s 10-K dated March 26, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At Utah Medical Products, Inc.'s shareholder meeting held May 1, 2026, in the 2025-2026 proxy season, 155 asset managers reported how they voted in their SEC Form N-PX filings, covering 657 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To hold an advisory vote on the Company's executive compensation program. — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Utah Medical Products, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 4, 2026.

Utah Medical Products, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.